Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D T Vistica

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Neurotoxicology|January 1, 1997
Histological, histochemical and autoradiographic evidence of in vitro neurotoxic effects of the novel antitumor agent, 9-methoxy-N2-methylellipticinium acetateL Shankar, V Ravindranath, M R Boyd, et al.
Experimental Cell Research|April 25, 2000
Selective accumulation of the endoplasmic reticulum-Golgi intermediate compartment induced by the antitumor drug KRN5500M Kamishohara, S Kenney, R Domergue, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Affinity of antineoplastic amino acid drugs for the large neutral amino acid transporter of the blood-brain barrierY Takada, N H Greig, D T Vistica, et al.
Cancer Treatment Reports|August 1, 1979
Mechanisms of sensitivity or resistance of murine tumors to N-(phosphonacetyl)-L-aspartate (PALA)H N Jayaram, D A Cooney, D T Vistica, et al.
Cancer Research|May 15, 1991
Tetrazolium-based assays for cellular viability: a critical examination of selected parameters affecting formazan productionD T Vistica, P Skehan, D Scudiero, et al.
Journal of Medicinal Chemistry|March 1, 1987
Selective cytotoxicity of a system L specific amino acid nitrogen mustardD R Haines, R W Fuller, S Ahmad, et al.
Cancer Research|April 15, 1992
Rapid high-affinity transport of a chemotherapeutic amino acid across the blood-brain barrierY Takada, D T Vistica, N H Greig, et al.
Biochemical Pharmacology|May 7, 1999
Selective toxicity of the tricyclic thiophene NSC 652287 in renal carcinoma cell lines: differential accumulation and metabolismM I Rivera, S F Stinson, D T Vistica, et al.
Journal of Medicinal Chemistry|July 8, 1994
Anticancer specificity of some ellipticinium salts against human brain tumors in vitroE M Acton, V L Narayanan, P A Risbood, et al.
Cancer Research|November 1, 1984
Potentiation of melphalan cytotoxicity in human ovarian cancer cell lines by glutathione depletionJ A Green, D T Vistica, R C Young, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Neurotoxicology|January 1, 1997
Histological, histochemical and autoradiographic evidence of in vitro neurotoxic effects of the novel antitumor agent, 9-methoxy-N2-methylellipticinium acetateL Shankar, V Ravindranath, M R Boyd, et al.
Experimental Cell Research|April 25, 2000
Selective accumulation of the endoplasmic reticulum-Golgi intermediate compartment induced by the antitumor drug KRN5500M Kamishohara, S Kenney, R Domergue, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Affinity of antineoplastic amino acid drugs for the large neutral amino acid transporter of the blood-brain barrierY Takada, N H Greig, D T Vistica, et al.
Cancer Treatment Reports|August 1, 1979
Mechanisms of sensitivity or resistance of murine tumors to N-(phosphonacetyl)-L-aspartate (PALA)H N Jayaram, D A Cooney, D T Vistica, et al.
Cancer Research|May 15, 1991
Tetrazolium-based assays for cellular viability: a critical examination of selected parameters affecting formazan productionD T Vistica, P Skehan, D Scudiero, et al.
Journal of Medicinal Chemistry|March 1, 1987
Selective cytotoxicity of a system L specific amino acid nitrogen mustardD R Haines, R W Fuller, S Ahmad, et al.
Cancer Research|April 15, 1992
Rapid high-affinity transport of a chemotherapeutic amino acid across the blood-brain barrierY Takada, D T Vistica, N H Greig, et al.
Biochemical Pharmacology|May 7, 1999
Selective toxicity of the tricyclic thiophene NSC 652287 in renal carcinoma cell lines: differential accumulation and metabolismM I Rivera, S F Stinson, D T Vistica, et al.
Journal of Medicinal Chemistry|July 8, 1994
Anticancer specificity of some ellipticinium salts against human brain tumors in vitroE M Acton, V L Narayanan, P A Risbood, et al.
Cancer Research|November 1, 1984
Potentiation of melphalan cytotoxicity in human ovarian cancer cell lines by glutathione depletionJ A Green, D T Vistica, R C Young, et al.
Pageof 4